CEO Thomas Schinecker claimed the company has “many opportunities” to stand out in the competitive field, and can get to market “much faster” than investors expect.
More from Ben Fidler
Roche says it’ll move quickly with ‘differentiated’ obesity drugs
No Comments
Leave a comment Cancel